NF-κB: An essential transcription factor in psoriasis
Goldminz, A.M, Au, S.C, Kim, N, Gottlieb, A.B, Lizzul, P.F
Published in Journal of dermatological science (01.02.2013)
Published in Journal of dermatological science (01.02.2013)
Get full text
Journal Article
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)
Blauvelt, A., Prinz, J.C., Gottlieb, A.B., Kingo, K., Sofen, H., Ruer-Mulard, M., Singh, V., Pathan, R., Papavassilis, C., Cooper, S.
Published in British journal of dermatology (1951) (01.02.2015)
Published in British journal of dermatology (1951) (01.02.2015)
Get full text
Journal Article
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
Papp, K.A., Menter, M.A., Abe, M., Elewski, B., Feldman, S.R., Gottlieb, A.B., Langley, R., Luger, T., Thaci, D., Buonanno, M., Gupta, P., Proulx, J., Lan, S., Wolk, R.
Published in British journal of dermatology (1951) (01.10.2015)
Published in British journal of dermatology (1951) (01.10.2015)
Get full text
Journal Article
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial
Papp, K., Thaçi, D., Reich, K., Riedl, E., Langley, R.G., Krueger, J.G., Gottlieb, A.B., Nakagawa, H., Bowman, E.P., Mehta, A., Li, Q., Zhou, Y., Shames, R.
Published in British journal of dermatology (1951) (01.10.2015)
Published in British journal of dermatology (1951) (01.10.2015)
Get full text
Journal Article
Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis
Langley, R.G., Papp, K., Gottlieb, A.B., Krueger, G.G., Gordon, K. B., Williams, D., Valdes, J., Setze, C., Strober, B.
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2013)
Published in Journal of the European Academy of Dermatology and Venereology (01.10.2013)
Get full text
Journal Article
Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks
Krishnan, R., Cella, D., Leonardi, C., Papp, K., Gottlieb, A.B., Dunn, M., Chiou, C.F., Patel, V., Jahreis, A.
Published in British journal of dermatology (1951) (01.12.2007)
Published in British journal of dermatology (1951) (01.12.2007)
Get full text
Journal Article
Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis
Leonardi, C., Menter, A., Hamilton, T., Caro, I., Xing, B., Gottlieb, A.B.
Published in British journal of dermatology (1951) (01.05.2008)
Published in British journal of dermatology (1951) (01.05.2008)
Get full text
Journal Article
O282 EFFICACY AND SAFETY OF ADALIMUMAB TREATMENT IN WOMEN WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA: ANALYSIS FROM THE PLACEBO-CONTROLLED PORTION OF A PHASE II, RANDOMIZED, DOUBLE-BLIND STUDY
Gottlieb, A.B., Menter, A., Belknap, K., Chen, K., Teixeira, H.D.
Published in International journal of gynecology and obstetrics (01.10.2012)
Published in International journal of gynecology and obstetrics (01.10.2012)
Get full text
Journal Article
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)
Paul, C., Cather, J., Gooderham, M., Poulin, Y., Mrowietz, U., Ferrandiz, C., Crowley, J., Hu, C., Stevens, R.M., Shah, K., Day, R.M., Girolomoni, G., Gottlieb, A.B.
Published in British journal of dermatology (1951) (01.12.2015)
Published in British journal of dermatology (1951) (01.12.2015)
Get full text
Journal Article
P50 Increasingly Stringent Clinical Responses and the Association with Improvements in Pain, HRQoL, and Work Productivity in Patients with Hidradenitis Suppurativa: 16-Week Results from Phase 3 Studies BE HEARD I&II
Gottlieb, A.B., Mørup, M., Davis, L., Lukowski, B., Lambert, J., Horvath, B.
Published in Value in health (01.06.2024)
Published in Value in health (01.06.2024)
Get full text
Journal Article
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
Papp, K.A., Reich, K., Paul, C., Blauvelt, A., Baran, W., Bolduc, C., Toth, D., Langley, R.G., Cather, J., Gottlieb, A.B., Thaçi, D., Krueger, J.G., Russell, C.B., Milmont, C.E., Li, J., Klekotka, P.A., Kricorian, G., Nirula, A.
Published in British journal of dermatology (1951) (01.08.2016)
Published in British journal of dermatology (1951) (01.08.2016)
Get full text
Journal Article
MSR52 Defining Severity Category Thresholds to Guide Psoriasis Symptoms and Impacts Measure Score Interpretation Using Pooled Data from Three Phase 3 Trials in Plaque Psoriasis
Augustin, M., Gottlieb, A.B., Warham, R., Lambert, J., Hoepken, B., Warren, R.B.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article
293 Ixekizumab demonstrates comprehensive psoriasis clearance in patients with moderate-to-severe psoriasis with scalp, nail, and/or palmoplantar involvement: Uncover-1, -2 trials through 5 years
Gottlieb, A.B., Merola, J., Somani, N., Konicek, B., See, K., McKean-Matthews, M., Gallo, G., Rich, P.
Published in Journal of investigative dermatology (01.08.2022)
Published in Journal of investigative dermatology (01.08.2022)
Get full text
Journal Article
Open‐label, investigator‐initiated, single‐site exploratory trial evaluating secukinumab, an anti‐interleukin‐17A monoclonal antibody, for patients with moderate‐to‐severe hidradenitis suppurativa
Prussick, L., Rothstein, B., Joshipura, D., Saraiya, A., Turkowski, Y., Abdat, R., Alomran, A., Zancanaro, P., Kachuk, C., Dumont, N., Gottlieb, A.B., Rosmarin, D.
Published in British journal of dermatology (1951) (01.09.2019)
Published in British journal of dermatology (1951) (01.09.2019)
Get full text
Journal Article
A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process
Thorlacius, L., Ingram, J.R., Villumsen, B., Esmann, S., Kirby, J.S., Gottlieb, A.B., Merola, J.F., Dellavalle, R., Nielsen, S.M., Christensen, R., Garg, A., Jemec, G.B.E.
Published in British journal of dermatology (1951) (01.09.2018)
Published in British journal of dermatology (1951) (01.09.2018)
Get full text
Journal Article
苏金单抗治疗掌跖银屑病的研究
Gottlieb, A.B., Kubanov, A., Doorn, M., Sullivan, J., Papp, K.A., You, R., Regnault, P., Frueh, J.A.
Published in British journal of dermatology (1951) (01.04.2020)
Published in British journal of dermatology (1951) (01.04.2020)
Get full text
Journal Article